ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2025

The Shengmai San Exerts Therapeutic Effects on Type 2 Diabetes by Modulating the PI3K/AKT/GSK3B Signaling Pathway.

Hongchao Shang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.